Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: A structural equation model analysis

AIDS

Volumn 28, Issue 3, 2014, Pages 355-364

  Kapetanovic, Suad ^a   Griner, Ray ^b   Zeldow, Bret ^b   Nichols, Sharon ^c   Leister, Erin ^b   Gelbard, Harris A ^d   Miller, Tracie L ^e   Hazra, Rohan ^f   Mendez, Armando J ^e   Malee, Kathleen ^g   Kammerer, Betsy ^h   Williams, Paige L ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

HIV affected children; Inflammatory markers; Neurodevelopmental outcomes; Perinatal HIV infection

Indexed keywords

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84894038507     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000072     Document Type: Article

References (37)

1. Le Doaré K, Bland R, Newell ML. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 2012; 130:e1326-e1344.
2. Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J 2012; 31:592-598.
3. Donenberg GR, Pao M. Youths and HIV/AIDS: psychiatry's role in a changingepidemic. J Am Acad Child Adolesc Psychiatry 2005; 44:728-747.
4. Kapetanovic S, Leister E, Nichols S, Miller T, Tassiopoulos K, Hazra R, et al. Relationship between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth. AIDS 2010; 24:1481-1491.
5. Miller TL, Borkowsky W, DiMeglio LA, Dooley L, Geffner ME, Hazra R, et al. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med 2012; 13:264-275.
6. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6:21-29.
7. Papanicolaou DA, Vgontzas AN. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab 2000; 85:1331- 1333.
8. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94:3171-3182.
9. Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin- Dusting J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 2006; 98:149-156.
10. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296- 1301.
11. Wechsler D. Wechsler Intelligence Scale for children. 4th ed. San Antonio, Texas: Harcourt Assessment, Inc; 2003.
12. Reynolds CR, Kamphaus RW. Behavior assessment system for children. 2nd ed. Circle Pine, MN: American Guidance Service; 2004.
13. Johnson RA, Wichern DW. Applied multivariate statistical analysis. 5th ed.Prentice Hall; 2002: pp. 481-537.
14. Kaiser HF. An index of factorial simplicity. Psychometrika 1974; 39:31-36.
15. Fry AF, Hale S. Processing speed, working memory and fluid intelligence: evidence for a developmental cascade. Psychol Sci 1996; 7:237-241.
16. Pfefferbaum A, Mathalon DH, Sullivan EV, et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994; 51:874-887.
17. Palmer SL, Glass JO, Li Y, Ogg R, Qaddoumi I, Armstrong GT, et al. White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumor. Neuro Oncol 2012; 14:1185-1193.
18. Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 2012; 3:1227.
19. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol 2010; 22:347-352.
20. Kishimoto T. IL-6: from laboratory to bedside. Clin Rev Allergy Immunol 2005; 28:177-186.
21. Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 2013; 80:1415-1423.
22. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sørensen TU, Dreves AM, et al. Impaired progenitor cell function in HIVnegative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
23. Pedersen KK, Pedersen M, Gaardbo JC, Ronit A, Hartling HJ, Bruunsgaard H, et al. Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long term treatment with combination antiretroviral therapy. J Acquir Immune Defic Syndr 2013; 63:272-279.
24. Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, et al. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr 2012; 60:234-243.
25. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
26. Bunders M, Pembrey L, Kuijpers T, Newell ML. Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res Hum Retroviruses 2010; 26:967-975.
27. Ensoli F, Fiorelli V, Muratori DS, De Cristofaro M, Vincenzi L, Topino S, et al. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? Crit Rev Immunol 1999; 19:97-116Review.
28. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012; 12:330- 340.
29. Ciaranello AL, Ciaranello RD. The neurobiology of infantile autism. Annu Rev Neurosci 1995; 18:101-128.
30. Brown AS, Patterson PH. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 2011; 37:284- 290.
31. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. J Am Med Assoc Psychiatry 2013; 8:1-8.
32. Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009; 3:14.
33. Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 2007; 7:212.
34. vanWijk JP, Cabezas MC. Hypertriglyceridemia, metabolic syndrome, and cardiovascular disease in HIV-infected patients: effects of antiretroviral therapy and adipose tissue distribution. Int J Vasc Med 2012; 2012:201027.
35. Miller TL, Somarriba G, Orav EJ, Mendez AJ, Neri D, Schaefer N, et al. Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr 2010; 55:182-188.
36. Rönsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR. Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy. PLoS One 2013; 8:e65182.
37. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001; 184:1015- 1021.